Blog

From ScienceDaily.com: “Scientists have found a new family of molecules that kill cancer cells and protect healthy cells, which could be used to treat a number of different cancers. Research shows that as well as targeting and killing cancer cells,

Here’s the description: “A one-day event with leading influencers and visionaries to reimagine the American dream in an intimate setting at The Battery in San Francisco. NOVUS is a tour de force that unites global shapers from around the world

From the New Scientist: “Over the past few years, researchers have reversed muscle atrophy, memory loss, heart degradation and some of the effects of cognitive decline by pumping the blood of young mice into old mice. The results from these

From Business Insider: “It can take weeks to identify drugs targeting cancer-causing mutations. Watson can do it in minutes and has in its database the findings of scientific papers and clinical trials on particular cancers and potential therapies.”

From the LAT: “So far, the medical implant has been tested in three children between the ages of 3 months and 16 months. Before getting the implant, the young patients had spent much of their lives in intensive care, where

Scientists controlled a mouse’s behavior using a method called “DREADDs (designer receptors exclusively activated by designer drugs).” Not a great acronym (given the potential abuse for such a method), but it does reflect a shift away from linking mental “illnesses

From Phys.org: “What do you do when a patient needs a blood transfusion but you don’t have their blood type in the blood bank? It’s a problem that scientists have been trying to solve for years but haven’t been able

Here’s the latest news piece to cite 100 Plus. The author interviewed some naysayers on the topic of healthspan, but ultimately I think it’s clear that if Silicon Valley can figure out how to increase human health, that is a

Researchers at Duke University have engineered a polio virus to infect cancer cells. This weakens the cancer and alerts the body’s immune system to the fact that there is something growing in the body that shouldn’t be there. It’s brilliant

Here’s the story from Forbes. “The company has hired Richard Scheller, who led drug discovery at biotech icon Genentech for 14 years before announcing he would retire in December, and who has won some of science’s top awards, including the